Reduced number and function of insulin-secreting β-cells is a prominent feature of both type 1 and type 2 diabetes. Wagner and colleagues discuss strategies to promote β-cell proliferation, survival and function for the treatment of diabetes, and consider ongoing challenges to drug development efforts that are aimed at targeting this cell population.
- Amedeo Vetere
- Amit Choudhary
- Bridget K. Wagner